Products

Anti-Ovarian Carcinoma × Anti-CD3 Bi-specific T-cell engagers (BiTE) (BITE-LC001)

The anti-CD3/ovarian carcinoma are capapble of binding to T cells and ovarian carcinoma cell, and can be potentially used in the treatment of ovarian carcinoma.      

Specifications
Targets
Ovarian Carcinoma & CD3
Type
BiTE
Expression Host
CHO
Species Reactivity
Human
Target 1
Ovarian Carcinoma
Host
Mouse
Target 2
CD3
Host
Mouse
Purity
>95% judged by SDS-PAGE under reducing condition
Applications
ELISA
Related Disease
Ovarian carcinoma
Targets
Target 1
Ovarian Carcinoma
Target 2
CD3
Alternative Names
CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved